Boston Therapeutics
Lawrence, US
Biotech
Founders & leadership
CW
Colin W. NeillDirector
CC
Conroy Chi-Heng ChengDirector
CW
Carl W. RauschCEO
AW
Alan W. HobermanDirector
RW
Rom W. EliazChairman
Reported raises · per SEC filings
Form D private placements$8.4MraisedJul 2021 · 5 investors · Biotechnology
Rule 506(b)$1.6MraisedSep 2016 · 28 investors · Pharmaceuticals
Rule 506(b)Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.